Parathyroid Cancer Versus Atypical Parathyroid Neoplasm; Investigating Their Clinical Characteristics and Biological Behavior
| Status: | Completed |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/9/2018 |
| Start Date: | October 6, 2015 |
| End Date: | October 16, 2017 |
Objectives:
1. Identify the clinical characteristics of parathyroid (PTH) cancer and PTH atypical
neoplasms
2. Investigate if PTH carcinoma and atypical neoplasm present a biological behaviour and
have a different impact on the health of the patients
1. Identify the clinical characteristics of parathyroid (PTH) cancer and PTH atypical
neoplasms
2. Investigate if PTH carcinoma and atypical neoplasm present a biological behaviour and
have a different impact on the health of the patients
Data between the years of 1/1/2002 and 12/31/2013 will be analyzed. The medical records of
all adult patients that had a parathyroidectomy for primary PHPT in MD Anderson Cancer Center
will be screened in order to identify patients that had a histopathological diagnosis of
parathyroid carcinoma or atypical parathyroid neoplasm.
all adult patients that had a parathyroidectomy for primary PHPT in MD Anderson Cancer Center
will be screened in order to identify patients that had a histopathological diagnosis of
parathyroid carcinoma or atypical parathyroid neoplasm.
Inclusion Criteria:
- All patients from MDACC diagnosed with PHPT that have a histopathological diagnosis of
PTH carcinoma or atypical parathyroid neoplasm between the years 1/1/2002 and
12/31/2013
Exclusion Criteria:
- Pediatric patients
- Cases with incomplete records
- Patients where the follow-up will be less than six months
We found this trial at
1
site
1515 Holcombe Blvd
Houston, Texas 77030
Houston, Texas 77030
713-792-2121
University of Texas M.D. Anderson Cancer Center The mission of The University of Texas MD...
Click here to add this to my saved trials
